Ophthalmic nsaids as adjuvants

Details Ophthalmic nsaids as adjuvants Ophthalmic nsaids as adjuvants

A - Human Necessities

61

K

A61K 31/196 (2006.01) A61K 39/39 (2006.01) A61K 39/395 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2716110

The disclosure provides methods and ophthalmic NSAIDs as adjuvants to VEGF inhibitors useful for treating retinal disorders, including but not limited to wet AMD, diabetic retinopathy, diabetic macular edema, central retinal vein occlusion, and branch retinal vein occlusion.

Linvention concerne des procédés et des AINS ophtalmiques utilisés comme adjuvants aux inhibiteurs du facteur de croissance endothélial vasculaire utiles pour le traitement de troubles rétiniens, y compris, mais sans que ce soit limitatif, une DMA humide, une rétinopathie diabétique, un dème maculaire diabétique, une occlusion de la veine centrale de la rétine et une occlusion de la veine ramifiée de la rétine.

Affiliated with

Also associated with

Rating

Ophthalmic nsaids as adjuvants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic nsaids as adjuvants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic nsaids as adjuvants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1888713